General microbial metabolic enzymes

General microbial metabolic enzymes encompass a vast group of proteins required for the survival and replication of infectious agents such as bacteria and fungi (StatPearls, 2023). These enzymes catalyze indispensable reactions, including the assembly of the peptidoglycan cell wall, the synthesis of essential vitamins like folate, and the replication of the microbial genome (Nature Reviews Microbiology, 2021). Because these metabolic routes often differ significantly from human pathways, they are exploited as targets for antibiotics, antifungals, and antiparasitics to achieve selective toxicity (NCBI, 2022). For instance, beta-lactam antibiotics target penicillin-binding proteins to inhibit cell wall synthesis, while fluoroquinolones target topoisomerases to prevent DNA replication (PubMed, 2020). Despite their therapeutic utility, targeting these enzymes broadly can lead to the development of drug resistance and the destruction of beneficial host flora, presenting ongoing challenges in clinical medicine (WHO, 2023).

Other names

Microbial enzymesBacterial metabolic enzymesFungal metabolic enzymesMetabolic enzymes of microorganisms

Drugs targeting these enzymes typically function through competitive or non-competitive inhibition of essential metabolic pathways, such as the inhibition of dihydropteroate synthase in folate synthesis or the inhibition of transpeptidases in cell wall assembly (StatPearls, 2023; PubMed, 2020).